HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Guest Access | Sign In via User Name/Password

This Article Full Text Free Full Text (PDF) Free Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Article Archive Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (8) Citing Articles via Google Scholar Google Scholar Articles by Sakamaki, F. Articles by Ishida, Y. Search for Related Content PubMed PubMed Citation Articles by Sakamaki, F. Articles by Ishida, Y.

Abnormality of Left Ventricular Sympathetic Nervous Function Assessed by ¹²³I-Metaiodobenzylguanidine Imaging in Patients With COPD^*

^* From the Departments of Medicine (Drs. Sakamaki, Satoh, Nagaya, Kyotani, and Nakanishi) and Radiology (Dr. Ishida), National Cardiovascular Center, Osaka, Japan.

Correspondence to: Fumio Sakamaki, MD, Division of Cardiology and Pulmonary Circulation, Department of Medicine, National Cardiovascular Center, 5–7-1 Fujishirodai, Suita, Osaka 565-8565, Japan; e-mail: fsakamak{at}hsp.ncvc.go.jp

Background: Cardiac and systemic autonomic nervous function may be impaired in patients with COPD. Few reports, however, have described sympathetic nervous function of the left ventricle (LV) in COPD patients.

Study objective: To assess the LV sympathetic nervous function in patients with COPD using ¹²³I-metaiodobenzylguanidine (MIBG) imaging of the heart.

Design: Prospective comparison of ¹²³I-MIBG imaging results in COPD patients and normal subjects.

Participants: Twenty-eight patients with COPD without manifest right ventricular overload and 7 volunteers without cardiopulmonary disease (control subjects).

Measurements: ¹²³I-MIBG imaging results and plasma norepinephrine concentration were compared between the COPD and control groups. In the COPD group, pulmonary function tests were performed and all subjects were interviewed about their symptoms.

Results: ¹²³I-MIBG uptake, assessed as the cardiac to mediastinal activity ratio in the delayed image, was significantly lower in the COPD group than in the control group (p < 0.05). ¹²³I-MIBG turnover, expressed as the washout rate (WR) of ¹²³I-MIBG from 15 to 240 min, was significantly higher in the COPD group than in the control group (p < 0.01). In the COPD group, patients with dyspnea showed lower cardiac to mediastinal activity ratios and higher WRs compared with patients who had mild dyspnea. The WR correlated negatively with the vital capacity/predicted value ratio, correlated negatively with the maximal voluntary ventilation volume/predicted value ratio, and correlated positively with the residual volume/total lung capacity ratio in the COPD group. The plasma norepinephrine concentration in COPD patients was higher than that in the control subjects.

Conclusion: Patients with COPD have significant sympathetic nervous impairment of the LV myocardium as a result of generalized sympathetic overactivity.

Key Words: COPD • ¹²³I-metaiodobenzylguanidine • sympathetic nervous system

This article has been cited by other articles:

				S. Andreas, S. D. Anker, P. D. Scanlon, and V. K. Somers Neurohumoral Activation as a Link to Systemic Manifestations of Chronic Lung Disease Chest, November 1, 2005; 128(5): 3618 - 3624. [Abstract] [Full Text] [PDF]

				L. W. Raymond Vagal Pas de Deux: Heart-Lung Interplay in Postexercise Heart Rate Recovery Chest, April 1, 2004; 125(4): 1186 - 1190. [Full Text] [PDF]

				D D Sin and S F P Man Impaired lung function and serum leptin in men and women with normal body weight: a population based study Thorax, August 1, 2003; 58(8): 695 - 698. [Abstract] [Full Text] [PDF]